The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $173.26

Today's change+0.76 +0.44%
Updated June 26 11:36 AM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $173.26

Today's change+0.76 +0.44%
Updated June 26 11:36 AM EDT. Delayed by at least 15 minutes.

Amgen Inc up (U.S.)$0.76

Amgen Inc is up today by (U.S.)$0.76 or 0.44% to (U.S.)$173.26. Over the last five days, shares have gained 4.95% and 18.50% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $173.39
  • Previous close(U.S.) $172.50
  • High(U.S.) $173.88
  • Low(U.S.) $172.41
  • Bid / Ask(U.S.) $173.26 / (U.S.) $173.29
  • YTD % change+18.50%
  • Volume1,014,679
  • Average volume (10-day)5,148,657
  • Average volume (1-month)3,940,938
  • Average volume (3-month)3,761,845
  • 52-week range(U.S.) $133.64 to (U.S.) $184.21
  • Beta1.37
  • Trailing P/E16.42×
  • P/E 1 year forward13.87×
  • Forward PEG3.30×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.65%
  • Trailing EPS(U.S.) $10.55
Updated June 26 11:36 AM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue5,4645,9655,8115,688
Total other revenue--------
Total revenue5,4645,9655,8115,688
Gross profit4,4684,8984,7844,638
Total cost of revenue9961,0671,0271,050
Total operating expense2,8733,4803,2843,308
Selling / general / administrative1,0641,3231,2441,292
Research & development7691,078990900
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)---111078
Other operating expenses, total4412323-12
Operating income2,5912,4852,5272,380
Interest income (expense), net non-operating-326-328-325-313
Gain (loss) on sale of assets--------
Other--------
Income before tax2,4602,2832,4182,204
Income after tax2,0711,9352,0171,870
Income tax, total389348401334
Net income2,0711,9352,0171,870
Total adjustments to net income--------
Net income before extra. items2,0711,9352,0171,870
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0711,9352,0171,870
Inc. avail. to common incl. extra. items2,0711,9352,0171,870
Diluted net income2,0711,9352,0171,870
Dilution adjustment--------
Diluted weighted average shares741742753756
Diluted EPS excluding extraordinary itemsvalue per share2.792.612.682.47
Dividends per sharevalue per share1.151.001.001.00
Diluted normalized EPSvalue per share2.792.482.682.56